
Aster DM Healthcare vs Rainbow Children's Medicare: Share Price, Comparison and Key Differences
Aster DM Healthcare MCap approx Rs 28,000 Cr, PE approx 35x, ROE approx 12%. Rainbow Children's Medicare MCap Rs 16,000 Cr, PE 55.12x, ROE 16.89%, D/E 0.54.
Updated: 10 Aug 2026 • 1:54 pm
Posted by:

Aster DM Healthcare vs Rainbow Children's Medicare is a comparison investors look up when evaluating two listed Indian hospital chains with differentiated patient demographics and regional focuses. Aster DM Healthcare is a mid-size hospital group with strong operations in Kerala, Andhra Pradesh, Karnataka and Telangana in India – and has historically also operated in the GCC (Gulf) which is now under a separate listed entity post-restructuring. Rainbow Children's Medicare is a Hyderabad-based specialist paediatric, maternal and neonatal healthcare chain – one of very few listed pure-play children's hospitals globally.
This Aster DM Healthcare vs Rainbow Children's Medicare article covers reach and market position, key products, latest declared results and stock valuation. The Aster DM Healthcare vs Rainbow Children's Medicare data below is sourced from Groww and public company filings and reflects the most recently available information at the time of writing.
Aster DM Healthcare vs Rainbow Children's Medicare: Reach and Market Position
On the Aster DM Healthcare side of the Aster DM Healthcare vs Rainbow Children's Medicare comparison, Aster DM Healthcare operates hospitals, clinics and pharmacies in South India with a focus on affordable-to-mid segment care. Market capitalisation is approximately Rs 28,000 Cr.
Click Here – Get Free Investment Predictions
On the Rainbow Children's Medicare side of the Aster DM Healthcare vs Rainbow Children's Medicare comparison, Rainbow Children's Medicare operates 14+ Rainbow Hospitals in Hyderabad, Vijaywada, Bengaluru, Chennai, Vizag and Agra, specialising in paediatrics, neonatology, maternal health and reproductive medicine. Market capitalisation is Rs 16,000 Cr.
Aster DM Healthcare vs Rainbow Children's Medicare: Key Products and Business Mix
In the Aster DM Healthcare vs Rainbow Children's Medicare product comparison, Aster DM Healthcare offers: Aster DM earns from inpatient procedures and OPD at its hospital and clinic network. PE is approximately 35x, ROE approximately 12 percent.
For Rainbow Children's Medicare in this Aster DM Healthcare vs Rainbow Children's Medicare breakdown: Rainbow Children's earns from paediatric and maternal care across its specialty hospital network. EPS is Rs 28.58. PE is 55.12x, ROE 16.89 percent, D/E 0.54.
Aster DM Healthcare vs Rainbow Children's Medicare: Latest Results
The Aster DM Healthcare vs Rainbow Children's Medicare results for Aster DM Healthcare: Aster DM Healthcare has a market cap of approximately Rs 28,000 Cr. The company went through a restructuring to separate its India and GCC (Gulf) operations. ROE is approximately 12 percent.
The Aster DM Healthcare vs Rainbow Children's Medicare results for Rainbow Children's Medicare: Rainbow Children's Medicare has a market cap of Rs 16,000 Cr and PE of 55.12x. ROE is 16.89 percent – above the approximate Aster DM ROE. Rainbow's specialty paediatric model commands a premium for its unique positioning.
Compare Aster DM Healthcare and Rainbow Children's Medicare Fundamentals on the Univest Screener
Aster DM Healthcare vs Rainbow Children's Medicare: Stock and Valuation
The Aster DM Healthcare vs Rainbow Children's Medicare stock comparison uses the latest available market data from Groww. Investors tracking Aster DM Healthcare vs Rainbow Children's Medicare should verify current prices on NSE or BSE before trading.
Aster DM Healthcare vs Rainbow Children's Medicare at current valuations: Aster DM trades at approximately Rs 28,000 Cr market cap, PE approximately 35x, ROE approximately 12 percent. Rainbow trades at Rs 16,000 Cr market cap, PE 55.12x, ROE 16.89 percent. Aster DM is larger and cheaper on PE. Rainbow commands a premium for its specialty paediatric positioning.
Aster DM Healthcare vs Rainbow Children's Medicare: Quick Comparison Table
The Aster DM Healthcare vs Rainbow Children's Medicare comparison table below summarises the key metrics covered in this article side by side.
| Parameter | Aster DM Healthcare | Rainbow Children's Medicare |
|---|---|---|
| Sector | Multi-speciality hospital: South India (post-GCC split) | Paediatric and maternal specialty hospitals: South India |
| Market Cap | approximately Rs 28,000 Cr (approx) | Rs 16,000 Cr |
| P/E Ratio | approximately 35x (approx) | 55.12x (specialty premium) |
| ROE | approximately 12% (approx) | 16.89% |
| Specialisation | Multi-speciality primary and secondary care | Paediatrics, neonatology, maternal, reproductive medicine |
| Geographies | Kerala, AP, Karnataka, Telangana | Hyderabad, Bengaluru, Chennai, Agra |
| Dividend | Minimal | 0.22% yield |
Conclusion
The Aster DM Healthcare vs Rainbow Children's Medicare comparison above covers the key data points on reach, products, results and valuation. Aster DM Healthcare vs Rainbow Children's Medicare covers two hospital chains with very different patient profiles. Aster DM is a broad-based multi-speciality chain in South India. Rainbow is a specialty children's hospital chain – a unique and defensible segment. Aster DM vs Rainbow investors should review ARPOB, occupancy, Aster India restructuring impact and Rainbow's geographic expansion. Aster DM Healthcare vs Rainbow Children's Medicare each carry distinct hospital investment thesis – consult a SEBI-registered advisor for personalised guidance.
Download the Univest iOS App or Univest Android App to track Aster DM Healthcare and Rainbow Children's Medicare live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information, including company results filings and exchange data, and are current as of the time of writing. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What happened to Aster DM Healthcare's Gulf operations?
Ans. Aster DM Healthcare restructured its business, with the India operations operating under Aster DM Healthcare Ltd and the GCC (Gulf) hospital business being separately managed. This restructuring changed the profile of the listed India entity.
What does Rainbow Children's Medicare specialise in?
Ans. Rainbow Children's Medicare specialises exclusively in paediatrics (children's healthcare), neonatology (newborn intensive care), maternal and reproductive medicine. It is one of India's largest paediatric hospital chains.
Why does Rainbow command a premium PE?
Ans. Rainbow Children's operates in a specialty healthcare segment with fewer competitors than general hospitals. Its ARPOB for neonatal ICU care and complex paediatric surgery is very high, supporting premium margins.
Does Aster DM operate pharmacies?
Ans. Yes. Aster DM Healthcare operates Aster Pharmacy – a chain of retail pharmacies in South India – as part of its integrated healthcare model.
Are Aster DM and Rainbow in Nifty 50?
Ans. Neither is in Nifty 50. Both are tracked in Nifty Healthcare and Nifty 500 indices.
Is there a risk of geographic concentration for Rainbow?
Ans. Yes. Rainbow has heavy geographic concentration in Hyderabad and Andhra Pradesh. It is expanding to Bengaluru, Chennai and other cities to reduce this concentration.
Which is larger, Aster DM or Rainbow?
Ans. Aster DM Healthcare (approximately Rs 28,000 Cr) is larger than Rainbow Children's Medicare (Rs 16,000 Cr).
Recent Articles

Bajel Projects Q1 FY27 Results: Revenue Rs 566 Cr, PAT Rs 4.00 Cr and Key Highlights
10 August 2026

India Nippon Electricals Q1 FY27 Results: Revenue Rs 304 Cr, PAT Rs 27 Cr and Key Highlights
10 August 2026

Vindhya Telelinks Q1 FY27 Results: Revenue Rs 718 Cr, PAT Rs 15 Cr and Key Highlights
10 August 2026

Pokarna Q1 FY27 Results: Revenue Rs 189 Cr, PAT Rs 42 Cr and Key Highlights
10 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Bajel Projects Q1 FY27 Results: Revenue Rs 566 Cr, PAT Rs 4.00 Cr and Key Highlights
India Nippon Electricals Q1 FY27 Results: Revenue Rs 304 Cr, PAT Rs 27 Cr and Key Highlights
Vindhya Telelinks Q1 FY27 Results: Revenue Rs 718 Cr, PAT Rs 15 Cr and Key Highlights
Pokarna Q1 FY27 Results: Revenue Rs 189 Cr, PAT Rs 42 Cr and Key Highlights
Prism Johnson Q1 FY27 Results: Revenue Rs 1,835 Cr, PAT Rs 109 Cr and Key Highlights

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





